Inti Labs
Baytown
About Inti Labs
Inti Labs develops products and services focusing on reproductive health and fertility solutions. Their offerings include ora®, a device for monitoring ovulation and hormone levels; Opal, a system designed to improve embryo selection in fertility treatments; and Embryo46, a technology aimed at enhancing embryo assessment through advanced analytics. These products integrate data-driven approaches to support personalized reproductive care, aiming to improve outcomes by providing detailed insights tailored to individual biological profiles. They emphasize innovation in reproductive technology through combining hardware and software solutions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Jan 2024)
- Website: intilabs.com
- Phone: 4384051050
Industries & Categories
Biotechnology, Health Care, Hospital
Social Profiles
Canonical: https://fsome.com/organization/inti-labs-2426556 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.